Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

MDMA-Assisted Therapy for Mental Healthcare Providers

Rachel Yehuda · NCT07102576

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
30
US sites recruiting
1
Study start
February 11, 2026
Record last updated
March 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.

Being studied: MDMA Hydrochloride

Conditions: Mental Wellbeing

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Are at least 18 years at the time of signing the informed consent.
  • Fluent in English
  • Able to swallow pills
  • Agree to have study visits audiovisually recorded
  • Able to provide a contact (relative, spouse, close friend, or other support person) who is willing and able to be reached by the investigators in the event of the participant becoming unwell or unreachable.
  • Must be licensed, license-eligible, or trainees in a relevant healthcare/mental health profession
  • Must be learning or have been certified to conduct MDMA-assisted therapy through the Lykos MDMA-Assisted Therapy Training program or authorized affiliate program
  • Body weight of at least 45 kilograms (kg; or 100 pounds (lbs)).

Exclusion Criteria

  • Have engaged in a new form of psychiatric or mental health care within 12 weeks of enrollment
  • Have a current alcohol or cannabis use disorder of any severity within the 12 months prior to enrollment
  • Have a substance use disorder of any severity within 12 months prior to enrollment
  • Any suicidal ideation within the last 6 months
  • Repetitive or recent use of Ecstasy/MDMA
  • Current enrollment in any other clinical study involving an investigational study treatment or any other type of medical research, unless approved by the study clinician
  • Meet diagnostic criteria for a Major Depressive Episode currently or within the prior 3 months or meet diagnostic criteria for a current anxiety disorder assessed
  • Have a current eating disorder with compensatory behaviors
  • Have a history of, or a current primary psychotic disorder or bipolar disorder
  • Previous participation in a clinical trial that included administration of MDMA
  • Individuals in a personal relationship with the site investigator
  • Are pregnant or nursing or are able to become pregnant and are not practicing an effective means of contraception

Recruiting US locations

  • The Parsons Research Center for Psychedelic Healing

    New York, NY 10025

    Site contact: Tamar Glatman Zaretsky, PsyD · (914) 340-3669 · tamar.glatmanzaretsky@mssm.edu

Study contacts (from the official record)

  • Lily Fischer · 862-253-1938 · therapistwellbeing@mssm.edu
All mental health studies in New York →
MDMA-Assisted Therapy for Mental Healthcare Providers (NCT07102576) | Bored Studies